I’m working on several exciting projects. Some of these are late-stage projects focused on publishing our results. One manuscript, MEK inhibitor in rhabdomyosarcoma, has been
Recently, we collected multiple clear cell sarcoma cell lines and we are in the process of sequencing these cells so that we can learn more
As the newest lab member at cc-TDI, I began research on clear cell sarcoma in late November of 2018. My immediate goal is to collect
I study Diffuse Intrinsic Pontine Glioma (DIPG), an aggressive and hard treat form of brain tumor which primarily affects children between the ages of 4
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
Since pediatric cancers are (fortunately!) fairly rare, it’s ever more important for us to do our work with the spirit of collaboration. Thanks to the
I am working towards a cure for hepatoblastoma by testing medicines on a quail assay I have been developing. My work focuses on a quail
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
I joined cc-TDI half a year after it was founded, and my first major task at the lab was to begin operations and setup at
I’m working on several exciting projects. Some of these are late-stage projects focused on publishing our results. One manuscript, MEK inhibitor in rhabdomyosarcoma, has been
Recently, we collected multiple clear cell sarcoma cell lines and we are in the process of sequencing these cells so that we can learn more
As the newest lab member at cc-TDI, I began research on clear cell sarcoma in late November of 2018. My immediate goal is to collect
I study Diffuse Intrinsic Pontine Glioma (DIPG), an aggressive and hard treat form of brain tumor which primarily affects children between the ages of 4
To define the major endotypes, or pathobiological mechanisms, of embryonal rhabdomyosarcoma (ERMS) we’ve collected several human, mouse, and canine samples and clustered them together based
The last 6 months have been busy! Recently, I have been finishing up sets of experiments which help us understand the mode of action
Since pediatric cancers are (fortunately!) fairly rare, it’s ever more important for us to do our work with the spirit of collaboration. Thanks to the
I am working towards a cure for hepatoblastoma by testing medicines on a quail assay I have been developing. My work focuses on a quail
I’ll never forget the moment I found out that my cousin had cancer. It’s one of those moments you remember exactly where you were and
I joined cc-TDI half a year after it was founded, and my first major task at the lab was to begin operations and setup at
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2019 – Children’s Cancer Therapy Development Institute